Tweet This

Biosimilars User Fee Act

Creates an abbreviated licensure pathway for biologic products that are demonstrated to be “biosimilar” to or “interchangeable” with an FDA-licensed biologic product. This pathway is provided in the part of the law known as the Biologics Price Competition and Innovation Act (BPCI Act).

Quality Improvement Organization (QIO)

An organization tasked with reviewing the quality of care received by Medicare and Medicaid beneficiaries. Previously called a Peer Review Organization.